Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, signaling the industry could be next in line amid a trade war that is causing market turmoil.

Pharma stocks plummet as Trump signals steep tariffs on India's drug exports, with concerns over higher costs and profit margins. The US is reviewing tariffs on pharmaceuticals, raising uncertainty in the sector.